Lexy Staniland

Dr. Lexy Staniland

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Stigma and Health
Verified
Journal Article
Closed access
LSLexy Staniland
Lexy Staniland
PHPenelope Hasking
Penelope Hasking
Mark BoyesMark Boyes
Mark Boyes
SLStephen Lewis
Stephen Lewis

1 February 2022 in Deviant Behavior
Verified
Journal Article
Closed access
LSLexy Staniland
Lexy Staniland
PHPenelope Hasking
Penelope Hasking
SLStephen P. Lewis
Stephen P. Lewis
Mark BoyesMark Boyes
Mark Boyes
SMSylvanna Mirichlis
Sylvanna Mirichlis
Despite significant impacts to mental health and support-seeking, non-suicidal self-injury (NSSI) stigma remains under-studied and poorly understood. Recently, the NSSI Stigma Framework was proposed, conceptualizing NSSI stigma as comprising six constructs (origin, concealability, course, peril, aesthetics, disruptiveness) that manifest across four perspectives (public, self, anticipated, enacted). The present study investigated the extent to which this framework can account for individuals’ NSSI stigma experiences using a directed content analysis. Written responses from 99 university undergraduates (Mage = 21.5, SD = 3.7; 83.8% female) generated 731 data units for analysis, of which 299 (40.9%) were coded. Results demonstrated support for the public and enacted perspectives, with participants describing stigma experiences within friendships, families, schools, and workplaces. Data pointed to both direct and indirect experiences of public stigma, suggesting a more nuanced understanding of this perspective is required. While there was sufficient support for a majority of elements, more work is needed to verify the applicability of the self and anticipated perspectives. Our findings contribute to a growing body of research investigating NSSI stigma, and provide preliminary support for the utility of the NSSI Stigma Framework in identifying multiple facets of NSSI stigma. Implications for intervention and future research are discussed.

7 May 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
KRKristen S. Regenauer
Kristen S. Regenauer
ARAlexandra L. Rose
Alexandra L. Rose
JBJennifer M. Belus
Jennifer M. Belus
KJKim Johnson
Kim Johnson
NCNonceba Ciya
Nonceba Ciya
JMJessica F. Magidson
Jessica F. Magidson
South Africa has one of the highest rates of HIV/tuberculosis (TB) co-infection, and poor engagement in HIV/TB care contributes to morbidity and mortality. In South Africa, community health workers (CHWs) are tasked with re-engaging patients who have dropped out of HIV/TB care. CHWs have described substantial challenges with substance use (SU) and depression among their patients, while patients have described CHW stigma towards SU and depression as barriers to re-engagement in care. Yet, CHWs receive little-to-no training on SU or depression. Therefore, we piloted Siyakhana, a brief CHW training to reduce stigma related to SU and depression while improving skills for re-engaging these patients in HIV and/or TB care. This study evaluated the preliminary effectiveness (stigma towards SU and depression; clinical competence assessed via roleplay) and implementation (quantitative ratings of feasibility, acceptability, appropriateness, adoption; semi-structured written qualitative feedback) of Siyakhana among CHWs and supervisors (N = 17) at pre- and post-training assessments. SU stigma significantly decreased (F(1,16) = 18.94, p < 0.001, ηp2 = 0.54). Depression stigma was lower than SU stigma at both timepoints and did not significantly decrease after training. CHW clinical competency towards patients with SU/depression significantly improved (t(11) = -3.35, p = 0.007, d = 1.00). The training was rated as feasible, acceptable, appropriate, and likely to be adopted by CHWs and their supervisors. Nonjudgmental communication was commonly described as the most useful training component. Based on this pilot, the training is being refined and evaluated in a larger randomized stepped-wedge clinical trial.

6 October 2023 in Journal of Child and Family Studies
Verified
Journal Article
Open access
PDF file
CJCaitlin Joy
Caitlin Joy
LSLexy Staniland
Lexy Staniland
TMTrevor G. Mazzucchelli
Trevor G. Mazzucchelli
SSShelly Skinner
Shelly Skinner
LCLisa Cuddeford
Lisa Cuddeford
LBLauren J. Breen
Lauren J. Breen
While childhood bereavement is common, children’s bereavement needs are not well understood. It is recognized that children’s understandings of death fundamentally differ from those of adults, however, limited research has explored this from a child’s perspective. Insight about children’s understandings and needs can be drawn from the questions they ask about it. Bereaved children aged 5–12 years were invited to submit questions about death and grief during a camp for grieving children. Children’s questions (N = 213) from 10 camps were analyzed using conventional content analysis. Five themes were identified: Causes and Processes of Death; Human Intervention; Managing Grief; The Meaning of Life and Death; and After Death. Children’s questions revealed that they are curious about various biological, emotional, and existential experiences and concepts, demonstrating complex and multi-faceted considerations of death and its subsequent impact on their lives. Findings suggest that bereaved children may benefit from opportunities to freely discuss their thoughts about death, which may facilitate appropriate education and emotional support.

13 September 2023 in International Journal of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
SPSamantha Pilbrow
Samantha Pilbrow
LSLexy Staniland
Lexy Staniland
HUHannah Velure Uren
Hannah Velure Uren
FSFiona Shand
Fiona Shand
JMJaney McGoldrick
Janey McGoldrick
JMJoanna C. Moullin
Joanna C. Moullin
Background: With the pharmacist role extending internationally to include health promotion and harm reduction, pharmacists are well-suited to adopt a frontline role within suicide prevention efforts. To maximise their abilities to implement suicide prevention strategies, suicide prevention training is essential to improve pharmacists’ knowledge of, attitudes towards, and confidence in pharmacy-based suicide prevention. Aim: This study aimed to evaluate the impact of an online Advanced Suicide Prevention Training for Pharmacists and explore how participant feedback may direct training improvements. Method: One hundred and fifty pharmacists in Tasmania, Australia, completed the training. Of these, 109 participants completed surveys pre-, post- and 6-months post-training to evaluate changes in suicide prevention knowledge, confidence, and attitudes, and explore participants’ perceptions of the training. Results: Significant improvements were observed in suicide prevention attitudes (F(2, 20) = 4.12, p = 0.032, partial η2 = 0.292), and self-efficacy (F(2, 20) = 7.84, p = 0.003, partial η2 = 0.439), across the three timepoints, with improvements to knowledge and confidence evident between pre- and post-training (p < 0.05). Qualitative data reflected that the training was beneficial in aiding the identification and support of at-risk individuals, however barriers such as the pharmacy setting, personal discomfort, and perceptions of the pharmacist role were identified as impeding the implementation of suicide prevention within pharmacy practice. Conclusion: Training is an effective means of improving pharmacists’ suicide prevention knowledge, confidence, and attitudes. While personal barriers to suicide prevention improved, contextual and social barriers continue to impede pharmacists’ implementation of suicide prevention in practice.

5 March 2025 in Clinical Psychology Review
Verified
Journal Article
Open access
EFEmily Friedel
Emily Friedel
NVNandi Vijayakumar
Nandi Vijayakumar
LSLexy Staniland
Lexy Staniland
TSTimothy J. Silk
Timothy J. Silk
Individuals with ADHD may experience puberty differently from their peers, which has implications for their health and wellbeing. This scoping review characterised and summarised literature reporting quantitative analyses of puberty and ADHD. To identify studies, nine databases (MEDLINE Complete, Web of Science, Embase, PsycInfo, ERIC, CENTRAL, PsycExtra, WHO ICTRP, and ProQuest Dissertations & Theses) were searched using key terms related to puberty/pubertal hormones and ADHD/ADHD traits. From 2795 initial records, 89 studies were eligible. Relevant analyses in included studies were categorised under five topics: 1) pubertal group comparisons between participants with ADHD and control participants; 2) associations between puberty and ADHD; 3) prevalence of ADHD in atypical puberty conditions; 4) ADHD medication effects on puberty; and 5) puberty and co-occurring psychological conditions. With some exceptions, summarised findings for each topic were generally inconsistent, indicating further well-planned primary studies are needed. A framework for future research is provided, recommending methodological improvements, including use of approaches that capture the complexities of puberty and ADHD, more inclusive sampling, and employing theories/models that recognise dynamics between puberty, psychological, social, and other biological factors. Additionally, it is recommended that research priorities in this area are identified in collaboration with key stakeholders, especially the ADHD community.